Wiggin and Dana latest firm to bolster life sciences team

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Wiggin and Dana latest firm to bolster life sciences team

Cassidy_Kate_Hi.jpg
Kate Cassidy

Kate Cassidy expects that AI and developing deals will create a demand for strong life sciences litigators

Wiggin and Dana has added its name to the list of firms expanding their life sciences team with the addition of a new partner.

The firm announced yesterday, March 4, that litigator Kate Cassidy has joined the firm’s New York office. She joins from litigation boutique LTL Attorneys.

Cassidy told Managing IP that she was drawn to the firm because it has a “deep bench” in life sciences and pharma.

“It complemented what I was doing and what my practice is in terms of litigating in the pharma and life sciences space,” she said.

This news comes shortly after a couple of other firms also made major life sciences hires this year.

Fish & Richardson snagged a life sciences litigation duo from Jenner & Block in February, and Cahill Gordon & Reindel brought on two life sciences litigators from White & Case in January.

Cassidy added that life sciences and pharma companies have an interesting path ahead for the next year given the rise of artificial intelligence, as well as potential deals that are developing in the market.

“I think they’ll need really strong attorneys and litigators who can provide excellent services, and that’s why I thought that Wiggin and Dana would be a match for what I do,” she said.

In addition to her litigation work, Cassidy also has experience in arbitration. But work in this space will depend on her clients’ needs.

“Sometimes clients that spend a lot of time litigating also have some arbitration matters. Being a trial attorney, you need to have the advocacy skills whether you’re presenting them in arbitration or in front of a jury,” she said.

“If those opportunities come my way, that’s something the Wiggin and Dana team and I will be able to handle for people.”

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article